Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

  1. Murray, M.
  2. Antela, A.
  3. Mills, A.
  4. Huang, J.
  5. Jäger, H.
  6. Bernal, E.
  7. Lombaard, J.
  8. Katner, H.
  9. Walmsley, S.
  10. Khuong-Josses, M.-A.
  11. Hudson, K.
  12. Dorey, D.
  13. Griffith, S.
  14. Spreen, W.
  15. Vanveggel, S.
  16. Shaefer, M.
  17. Margolis, D.
  18. Chounta, V.
Revue:
AIDS and Behavior

ISSN: 1573-3254,  1090-7165

Année de publication: 2020

Volumen: 24

Número: 12

Pages: 3533-3544

Type: Article

DOI: 10.1007/S10461-020-02929-8 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus